Enhancement of brain noradrenaline and dopamine turnover by thyrotropin-releasing hormone and its analogue NS-3 in mice and rats

Pharmacology and Toxicology

Volumn 78, Issue 6, 1996, Pages 421-428

  Itoh, Yoshinori ^a   Yamazaki, Akira ^a   Ukai, Yojiro ^a   Yoshikuni, Yoshiaki ^a   Kimura, Kiyoshi ^a  

^a NIPPON SHINYAKU CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; METIROSINE; MONOAMINE; MONTIRELIN; NORADRENALIN; PROBENECID; PROTIRELIN; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; CATECHOLAMINE METABOLISM; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; NORADRENALIN BRAIN LEVEL; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0029943948     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1996.tb00230.x     Document Type: Article

References (39)

1. Bacopoulos, N. G. & R. K. Bhatnagar: Correlation between tyrosine hydroxylase activity and catecholamine concentration or turnover in brain regions. J. Neurochem. 1977, 29, 639-643.
2. Bauer, K.: Thyroliberin analogues as competitive inhibitors of thyroliberin degradation by brain enzymes. Hoppe-Seyler's Z. Physiol. Chem. 1979, 360, 1126.
3. Beale, J. S., R. P. White & S. P. Huang: EEG and blood pressure effects of TRH in rabbits. Neuropharmacol. 1977, 16, 499-506.
4. Breese, G. R., J. M. Cott, B. R. Cooper, A. J. Prange, Jr., M. A. Lipton & N. P. Plotnikoff: Effects of thyrotropin-releasing hormone (TRH) on the actions of pentobarbital and other centrally acting drugs. J. Pharmacol. Exp. Therap. 1975, 193, 11-22.
5. Brodie, B. B., E. Costa, A. Dlabac, N. H. Neff & H. H. Smookler: Application of steady state kinetics to the estimation of synthesis rate and turnover time of tissue catecholamines. J Pharmacol. Exp. Therap. 1966, 154, 493-498.
6. Constantinidis, J., F. Geissbühler, J. M. Gaillard, T. H. Hovanguimian & R. Tissot: Enhancement of cerebral noradrenaline turnover by thyrotropin releasing hormone: evidence by fluorescence histochemistry. Experientia 1974, 30, 1182-1183.
7. Crespi, F., P. E. Keane & M. Morre: In vivo evaluation by differential pulse voltammetry of the effect of thyrotropin-releasing hormone (TRH) on dopaminergic and serotoninergic synaptic activity in the striatum and nucleus accumbens of the rat. Exp. Brain Res. 1986, 62, 329-334.
8. Flohé, L., K. Bauer, E. Friderichs, W. A. Günzler, H. H. Hennies, S. Herring, F. Lagler, F. Ötting & E. Schwertner: Biological effects of degradation-stabilized TRH analogues. In: Thyrotropin-releasing hormone. Eds.: E.C. Griffiths & G.W. Bennett. Raven Press, New York. 1983, pp. 327-340.
9. 3H]DOPA in various regions of the brain. J. Neurochem. 1966, 13, 655-669.
10. Heal, D. J., N. Stoodley, J. M. Elliott, C. A. Marsden, G. W. Bennett & M. B. H. Youdim: Behavioural and biochemical evidence for the release of noradrenaline in mouse brain by TRH and some of its biologically stable analogues. Neuropharmacol. 1987, 26, 313-322.
11. Hennies, H. H.& L. Flohé: Effects of the thyroliberin analogue CG 3703 on noradrenergic and serotoninergic transmission in rodents. Biochem. Pharmacol. 1982, 31, 2430-2432.
12. Horita, A., M. A. Carino & R. M. Chesnut: Influence of thyrotropin releasing hormone (TRH) on drug-induced narcosis and hypothermia in rabbits. Psychopharmacol. 1976, 49, 57-62.
13. Horita, A., M. A. Carino & H. Lai: Pharmacology of thyrotropin-releasing hormone. Ann. Rev. Pharmacol. Toxicol. 1986, 26, 311-332.
14. Horst, W. D.& N. Spirt: A possible mechanism for the anti-depressant activity of thyrotropin releasing hormone. Life Sci. 1974, 15, 1073-1082.
15. Hökfelt, T., K. Fuxe, O. Johansson, S. Jeffcoate.& N. White: Thyrotropin-releasing hormone (TRH)-containing nerve terminals in certain brain stem nuclei and in the spinal cord. Neurosci. Lett. 1975a, 1, 133-139.
16. Hökfelt, T., K. Fuxe, O. Johansson, S. Jeffcoate & N. White: Distribution of thyrotropin-releasing hormone (TRH) in the central nervous system as revealed with immunohistochemistry. Eur. J. Pharmacol. 1975b, 34, 389-392.
17. Itoh, Y., T. Ogasawara, A. Yamazaki, Y. Ukai, A. Miura & K. Kimura: Enhancement of noradrenaline release from rat frontal cortex by thyrotropin releasing hormone and its analog. (3R.6R)-6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamide, as studied by intracerebral microdialysis. J. Pharmacol. Exp. Therap. 1994, 268, 255-261.
18. Itoh, Y., T. Sugimoto, Y. Ukai, A. Morino & K. Kimura: Permeability of NS-3, a thyrotropin-releasing hormone analog, into brain after its systemic administration in rats: A microdialysis study. J. Pharm. Pharmacol. 1995, 47, 833-836.
19. Kalivas, P. W., D. Stanley & A. J. Prange, Jr.: Interaction between thyrotropin-releasing hormone and the mesolimbic dopamine system. Neuropharmacol. 1987, 26, 33-38.
20. Keller, H. H., G. Bartholini & A. Pletscher: Enhancement of cerebral noradrenaline turnover by thyrotropin-releasing hormone. Nature 1974, 248, 528-529.
21. 3H]-dopamine from slices of rat nucleus accumbens in vitro. Br. J. Pharmacol. 1979, 67, 323-325.
22. Marek, K. & D. R. Haubrich: Thyrotropin-releasing hormone-increased catabolism of catecholamines in brains of thyroidectomized rats. Biochem. Pharmacol. 1977, 26, 1817-1818.
23. Miyamoto, M. & Y. Nagawa: Mesolimbic involvement in the locomotor stimulant action of thyrolropin-releasing hormone (TRH) in rats. Eur. J. Pharmacol. 1977, 44, 143-152.
24. Moore, K. E. & P. H. Kelly: Biochemical pharmacology of mesolimbic and mesocortical dopaminergic neurons. In: Psychopharmacology: A generation of progress. Eds.: M. A. Lipton, A. Di-Mascio & K. F. Killam, Raven Press, New York, 1978, pp. 221-234.
25. Morley, J. E.: Extrahypothalamic thyrotropin-releasing hormone (TRH) - its distribution and its functions. Life Sci. 1979, 25, 1539-1550.
26. Neff, N. H., T. N. Tozer & B. B. Brodie: Application of steady-state kinetics to studies of the transfer of 5-hydroxyindoleacetic acid from brain to plasma. J. Pharmacol. Exp. Therap. 1967, 158, 214-218.
27. O'Cuinn, G., B. O'Connor & M. Elmore: Degradation of thyrotropin-releasing hormone and luteinizing hormone-releasing hormone by enzymes of brain tissue. J. Neurochem. 1990, 54, 1-13.
28. Ogasawara, T., Y. Ukai, M. Tamura, N. Taniguchi, K. Kimura & A. Sato: Effects of NS-3, an analogue of thyrotropin-releasing hormone, on the central nervous system. Biomed. Res. 1993, 14, 317-328.
29. Oka, M., Y. Ochi, K. Furukawa, T. Ito, Y. Miura, T. Karasawa & T. Kadokawa: L-6-Ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous system functions. Arzeim. Forsch. 1989, 39, 297-303.
30. Palacios, J. M.: Autoradiographic visualization of receptor binding sites for thyrotropin-releasing hormone in the rodent brain. Eur. J. Pharmacol. 1983, 92, 165-166.
31. Paxinos, G. & C. Watson: The rat brain in stereotaxic coordinates. Sydney, Academic Press, Sydney, 1982.
32. Pazos, A., R. Cortés & J. M. Palacios: Thyrotropin-releasing hormone receptor binding sites: Autoradiographic distribution in the rat and guinea pig brain. J. Neurochem. 1985, 45, 1448-1463.
33. Rastogi, R. B., R. L. Singhal & Y. D. Lapierre: Effects of MK-771, a novel TRH analog, on brain dopaminergic and serotonergic systems. Eur. J. Pharmacol. 1981, 73, 307-312.
34. Safran, M., C. F. Wu, R. Matys, S. Alex & C. H. Emerson: The pharmacokinetics of thyrotropin-releasing hormone (TRH) and deamido-TRH in the rat. Endocrinol. 1984, 115, 1031-1037.
35. Ukai, Y., T. Ogasawara, K. Ideguchi & K. Kimura: Electroencephalographical studies in the improvement of the disturbance of consciousness by TRH analogue, CNK-602A. Jap. J. Pharmacol. 1988, 46(Suppl), 243P.
36. Warnhoff, M.: Simultaneous determination of norepinephrine, dopamine, 5-hydroxytryptamine and their main metabolites in rat brain using high-performance liquid Chromatography with electrochemical detection. J. Chromatogr. 1984, 307, 271-281.
37. Yamada, K., K. T. Demarest & K. E. Moore: Effects of behaviorally active doses of thyrotropin-releasing hormone and its analog MK-771 on dopaminergic neuronal systems in the brain of the rat. Neuropharmacol. 1984, 23, 735-739.
38. Yarbrough, G. G.: Thyrotropin releasing hormone and CNS cholinergic neurons. Life Sci. 1983, 33, 111-118.
39. Zloković, B. V., M. B. Segal, D. J. Begley, H. Davson & L. Rakić: Permeability of the blood-cerebrospinal fluid and blood-brain barriers to thyrotropin-releasing hormone. Brain Res. 1985, 358, 191-199.